Comparison 63. SE ‐ Orthostatic symptoms.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Citalopram versus heterocyclics | 1 | 96 | Odds Ratio (M‐H, Random, 95% CI) | 1.0 [0.19, 5.22] |
1.1 versus Maprotiline | 1 | 96 | Odds Ratio (M‐H, Random, 95% CI) | 1.0 [0.19, 5.22] |
2 Citalopram versus newer ADs | 1 | Odds Ratio (M‐H, Random, 95% CI) | Subtotals only | |
2.1 versus Reboxetine | 1 | 357 | Odds Ratio (M‐H, Random, 95% CI) | 0.44 [0.13, 1.47] |